High-density lipoprotein-dependent effects of statins on the risk of coronary heart disease deaths and events.

Suppr

超能文献

作者信息

Takagi Hisato, Matsui Masafumi, Umemoto Takuya

出版信息

Int J Cardiol. 2011 Nov 3;152(3):377-9. doi: 10.1016/j.ijcard.2011.07.071. Epub 2011 Aug 17.

DOI:10.1016/j.ijcard.2011.07.071

PMID:21851993

Abstract

摘要

相似文献

High-density lipoprotein-dependent effects of statins on the risk of coronary heart disease deaths and events.

Int J Cardiol. 2011 Nov 3;152(3):377-9. doi: 10.1016/j.ijcard.2011.07.071. Epub 2011 Aug 17.

What the statin trials have taught us.

Am J Cardiol. 2006 Jul 1;98(1):129-34. doi: 10.1016/j.amjcard.2006.01.066. Epub 2006 May 6.

High-density lipoprotein and coronary heart disease: current and future therapies.

J Am Coll Cardiol. 2010 Mar 30;55(13):1283-99. doi: 10.1016/j.jacc.2010.01.008.

Should statins be given routinely in all coronary patients?

Int J Cardiol. 2009 Jul 10;135(3):399-401. doi: 10.1016/j.ijcard.2008.05.001. Epub 2008 Jun 20.

Statins for primary prevention of coronary artery disease.

Lancet. 2007 Mar 31;369(9567):1078; author reply 1079. doi: 10.1016/S0140-6736(07)60517-0.

The large clinical statin trials.

Int J Cardiol. 2011 Jul 1;150(1):108-11. doi: 10.1016/j.ijcard.2011.04.029. Epub 2011 May 28.

Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.

J Cardiovasc Pharmacol. 2008 Apr;51(4):331-51. doi: 10.1097/FJC.0b013e318165e2e7.

Current questions regarding the use of statins in patients with coronary heart disease.

Int J Cardiol. 2007 Nov 30;122(3):188-94. doi: 10.1016/j.ijcard.2006.12.030. Epub 2007 Mar 30.

High density lipoprotein cholesterol and apolipoprotein A-I are persistently elevated during long-term treatment with pitavastatin, a new HMG-CoA reductase inhibitor.

Int J Cardiol. 2010 Jun 11;141(3):320-2. doi: 10.1016/j.ijcard.2008.11.130. Epub 2009 Jan 12.

Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.

J Indian Med Assoc. 2006 Sep;104(9):492-4, 496, 498.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

High-density lipoprotein-dependent effects of statins on the risk of coronary heart disease deaths and events.

Int J Cardiol. 2011 Nov 3;152(3):377-9. doi: 10.1016/j.ijcard.2011.07.071. Epub 2011 Aug 17.

What the statin trials have taught us.

Am J Cardiol. 2006 Jul 1;98(1):129-34. doi: 10.1016/j.amjcard.2006.01.066. Epub 2006 May 6.

High-density lipoprotein and coronary heart disease: current and future therapies.

J Am Coll Cardiol. 2010 Mar 30;55(13):1283-99. doi: 10.1016/j.jacc.2010.01.008.

Should statins be given routinely in all coronary patients?

Int J Cardiol. 2009 Jul 10;135(3):399-401. doi: 10.1016/j.ijcard.2008.05.001. Epub 2008 Jun 20.

Statins for primary prevention of coronary artery disease.

Lancet. 2007 Mar 31;369(9567):1078; author reply 1079. doi: 10.1016/S0140-6736(07)60517-0.

The large clinical statin trials.

Int J Cardiol. 2011 Jul 1;150(1):108-11. doi: 10.1016/j.ijcard.2011.04.029. Epub 2011 May 28.

Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.

J Cardiovasc Pharmacol. 2008 Apr;51(4):331-51. doi: 10.1097/FJC.0b013e318165e2e7.

Current questions regarding the use of statins in patients with coronary heart disease.

Int J Cardiol. 2007 Nov 30;122(3):188-94. doi: 10.1016/j.ijcard.2006.12.030. Epub 2007 Mar 30.

High density lipoprotein cholesterol and apolipoprotein A-I are persistently elevated during long-term treatment with pitavastatin, a new HMG-CoA reductase inhibitor.

Int J Cardiol. 2010 Jun 11;141(3):320-2. doi: 10.1016/j.ijcard.2008.11.130. Epub 2009 Jan 12.

Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.

J Indian Med Assoc. 2006 Sep;104(9):492-4, 496, 498.